Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
05/2006
05/25/2006US20060111349 such as 3-[(Quinolin-4-ylmethyl)amino]-N-[4-methyl-3-(2-(4-(2-propyl)piperazin-1-yl)-3,4-dioxocyclobut-1-en-1-yl)phenyl]thiophene-2-carboxamide, having stem cell factor receptor inhibitory activity, used antitumor or anticarcinogenic agents
05/24/2006EP1659111A2 Piperidine derivatives useful as ccr5 antagonists
05/24/2006EP1658287A1 Pyridinylmorpholine derivatives
05/24/2006EP1658286A1 N-aryl-2-cyanooxazolidinones and their derivatives
05/24/2006EP1658285A1 Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide
05/24/2006EP1658284A1 3,5 disubstituted indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation
05/24/2006EP1658274A2 Inhibitors of cathepsin s
05/24/2006EP1658273A1 Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide
05/24/2006EP1658267A2 Inhibitors of cathepsin s
05/24/2006EP1658076A1 Aryloxy and arylalkyleneoxy substituted imidazoquinolines
05/24/2006EP1549639B1 Sulphonamide derivatives as antipsychotic agents
05/24/2006EP1501812A4 Pna monomer and precursor
05/24/2006EP1254904B1 Novel piperidine compounds and drugs containing the same
05/24/2006CN1777619A Compounds with anti-inflammatory activity
05/24/2006CN1777595A Derivatives of dioxane-2-alkyl carbamates, preparation thereof and application thereof in therapeutics
05/24/2006CN1777592A Quinoxaline derivatives, and organic semiconductor devices, electroluminescent devices and electronic appliances, made by using the derivatives
05/24/2006CN1777590A Indazole derivatives
05/24/2006CN1777427A Aminoheteroaryl compounds as protein kinase inhibitors
05/24/2006CN1775794A Azitromycin double salts and their preparing method and use
05/24/2006CN1775779A Diphenyl ether azole derivative bioelectronic transmission material, and its new preparing method and use
05/24/2006CN1775759A Bicyclic androgen and progesterone receptor modulator compounds and methods
05/23/2006US7049444 3-azabicyclo[3.1.0]hexane derivatives useful in therapy
05/23/2006US7049443 Such as 2-(3-(Acetyl(((5S)-3-(4-(1,1-dioxidotetrahydro-2H-thiopyran-4-yl)-3 -fluorophenyl)-2-oxo-1,3-oxazolidin-5-yl)meth yl)amino)-1,1-dimethyl-3-oxopropyl)-3,5-dimethylphenyl dihydrogen phosphate; improved bioavailability
05/23/2006US7049438 Quinazoline derivatives for treatment of tumours
05/23/2006US7049378 Polymerization of olefin
05/23/2006US7049320 Drugs for treating physiological disorder, respiratory disorders, inflammatory disease, skin disorder, and antidepressants, treating bipolar disorder, drug abuse, drug dependence, gastrointestinal disorder, atherosclerosis
05/23/2006US7049314 Cyclopentyl indole derivatives
05/23/2006US7049313 Induce immunology response; anticancer agents
05/23/2006US7049312 2H-1,4-benzothiazin-3(4H)-one derivative as anticarcinogenic and antiproliferative agent; inhibitors of serine/threonine and tyrosine kinase activity
05/23/2006US7049308 For therapy of inflammatory or painful disorder
05/23/2006US7049306 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4.
05/23/2006CA2291134C Method for the preparation of citalopram
05/23/2006CA2257200C Substituted imidazoles having cytokine inhibitory activity
05/23/2006CA2158454C Taxanes having furyl or thienyl substituted side-chain
05/18/2006WO2006053112A1 Process for preparing trisubstituted pyrimidine compounds
05/18/2006WO2006053109A1 Heteroaryl compounds
05/18/2006WO2006052190A1 Indazole sulphonamide derivatives
05/18/2006WO2006051851A1 2,3,4,5-tetrahydro-1h-1,5-benzodiazepine derivative and medicinal composition
05/18/2006WO2006051704A1 Imine compound
05/18/2006WO2006051408A1 Oxazolidinone derivatives as antimicrobials
05/18/2006WO2006051312A1 Gastrin and cholecystokinin receptor ligands
05/18/2006WO2005051301A3 Heterocyclic inhibitors of mek and methods of use thereof
05/18/2006US20060106218 Substituted piperazines
05/18/2006US20060106211 Group 9 or 10 metal complexes of N-(N-heterocycle-substuted)acridines, phenoxazines and phenothiazines that are capable of converting a triplet excitation state into light emission and excellent in heat resistance; electronic devices with low power consumption
05/18/2006US20060106090 Cytotoxic agents comprising taxanes and their therapeutic use
05/18/2006US20060106078 Prostamide receptor antagonists
05/18/2006US20060106062 Substituted 2-quinolyl-oxazoles useful as PDE4 inhibitors
05/18/2006US20060106061 PGD2 receptor antagonists for the treatment of inflammatory diseases
05/18/2006US20060106042 Substituted heterocyclpyrmidines
05/18/2006US20060106016 Dicarboxamide derivatives
05/18/2006US20060105997 Mitotic kinesin inhibitors
05/18/2006US20060105927 Colorant compositions
05/18/2006US20060105416 For the determination of an analyte or analytes such as proteins, peptides, nucleic acids, carbohydrates, lipids, steroids and small molecules by mass analysis
05/18/2006CA2587667A1 Imine compound
05/18/2006CA2586870A1 Il-12 modulatory compounds
05/17/2006EP1657238A1 Fused pyrimidine derivative and use thereof
05/17/2006EP1656372A2 2,4-pyrimidinediamine compounds for use in the treatment or prevention of autoimmune diseases
05/17/2006EP1656371A2 Novel oxazoles, their manufacture and use as pharmaceutical agents
05/17/2006EP1656370A2 Biaryl heterocyclic compounds and methods of making and using the same
05/17/2006EP1656368A2 Substituted hertocyclic derivatives useful as antidiabetic and antiobesity agents and method
05/17/2006EP1656367A1 4- (heterocyclyl- fused phenyl)- 3- (phenyl or pyrid -2- yl) pyrazoles as inhibitors of the alk-5- receptor
05/17/2006EP1656357A1 Oxazolidinone antibiotics and derivatives thereof
05/17/2006EP1656355A2 Piperazine derivatives and methods of use
05/17/2006EP1656346A1 Novel substituted 3-sulfur indoles
05/17/2006EP1656345A1 Cyclic derivatives as modulators of chemokine receptor activity
05/17/2006EP1656138A2 Substituted cycloalkyamine derivatives as modulators of chemokine receptor activity
05/17/2006EP1656132A2 Novel pyrrole-based hmg-coa reductase inhibitors
05/17/2006EP1656096A2 Methods of reducing risk of infection from pathogens
05/17/2006EP1345929B1 Pyrazole compounds useful as protein kinase inhibitors
05/17/2006EP1345927B1 Pyrazole compounds useful as protein kinase inhibitors
05/17/2006EP1345926B1 Pyrazole compounds useful as protein kinase inhibitors
05/17/2006EP1345925B1 Pyrazole compounds useful as protein kinase inhibitors
05/17/2006EP1317452B1 Pyrazole compounds useful as protein kinase inhibitors
05/17/2006EP1317447B1 Pyrazole compounds useful as protein kinase inhibitors
05/17/2006EP1246810B1 Piperidinyloxy and pyrrolidinyloxyphenyl oxazolidinones as antibacterials
05/17/2006EP1114035B1 Quinazoline derivatives and pharmaceutical applications thereof
05/17/2006CN1774435A Five-membered heterocyclic derivative
05/17/2006CN1774418A Substituted N-arylheterocycles, method for production and use thereof as medicaments
05/17/2006CN1772751A Substituted oxazolidinones and their use in the field of blood coagulation
05/17/2006CN1772750A Prepn process of (R)-N-(3-fluoro-4-morpholinyl phenyl)-oxazolone-5-methyl alcohol
05/17/2006CN1256329C Herbicidal substituted benzoylpyrazoles
05/17/2006CN1256328C Position seven substituted amine methyl fluoro quinolone derivative having antibacterial activity and its preparation method
05/17/2006CN1256326C 4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency
05/17/2006CN1256324C Pyrrolidine derivatives as factor Xa inhibitors
05/16/2006US7045660 [di(ether or thioether)heteroaryl or fluoro substituted aryl] compound or an N-oxide thereof or a salt thereof, useful for inhibiting the production or physiological effects of TNF in treatment of a patient suffering from a disease state associated with a detrimental excess of tumor necrosis factor
05/16/2006US7045625 Asymmetric process for the preparation of diarylethylpiperazines derivatives and novel asymmetric diarylmethylamines as intermediates
05/16/2006US7045539 Therapeutic benzoxazole compounds
05/16/2006US7045526 Substituted 4-amino-2-aryl-tetrahydroquinazolines, their preparation, their use and pharmaceutical preparations comprising them
05/16/2006US7045520 Opioid receptor active compounds
05/16/2006US7045519 Pyrimidine or pyridine derivatives
05/16/2006US7045516 Irritable bowel diosrders; gastrointestinal disorders; diarrhea
05/16/2006US7045514 Therapeutic heterocyclic compounds
05/16/2006CA2192797C Indolinone compounds for the treatment of disease
05/11/2006WO2006050506A1 Mediators of hedgehog signaling pathways, compositions and uses related thereto
05/11/2006WO2006048771A1 Novel tetrazole derivatives as positive allosteric modulators of metabotropic glutamate receptors
05/11/2006WO2006048209A1 Novel bradykinin b1 antagonists, method for producing the same and the use thereof as drugs
05/11/2006WO2005086892A3 Ion channel modulators
05/11/2006WO2005070924A8 Substituted quinolines and their use as mycobacterial inhibitors
05/11/2006US20060100427 Alzheimer's disease and other diseases relating to amyloid deposits; neurodegenerative diseases
05/11/2006US20060100425 Indole acetic acids exhibiting CRTH2 receptor antagonism and uses thereof